Therapeutic effect of a MUC1-specific monoclonal antibody-drug conjugates against pancreatic cancer model

BACKGROUND: Pancreatic cancer is one of the most aggressive malignancies without effective targeted therapies. MUC1 has emerged as a potential common target for cancer therapy because it is overexpressed in a variety of different cancers including the majority of pancreatic cancer. However, there ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Guang, Li, Lan, Liu, Mengnan, Chen, Chunyan, Wang, Guangze, Jiang, Zewei, Qin, Yaqian, He, Licai, Li, Hongzhi, Cao, Jiawei, Gu, Haihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793597/
https://www.ncbi.nlm.nih.gov/pubmed/36572921
http://dx.doi.org/10.1186/s12935-022-02839-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793597/
https://www.ncbi.nlm.nih.gov/pubmed/36572921
http://dx.doi.org/10.1186/s12935-022-02839-w

Ejemplares similares